Skip to main content

Advertisement

Open Peer Review Reports for: Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
19 Dec 2017 Submitted Original manuscript
9 Jan 2018 Reviewed Reviewer Report - Taichi Hikichi
19 Jan 2018 Author responded Author comments - Martin K. Schmid
19 Jan 2018 Reviewed Reviewer Report - Harumasa Yokota
Resubmission - Version 2
19 Jan 2018 Submitted Manuscript version 2
13 Feb 2018 Author responded Author comments - Martin K. Schmid
Resubmission - Version 3
13 Feb 2018 Submitted Manuscript version 3
Publishing
23 Feb 2018 Editorially accepted
27 Feb 2018 Article published 10.1186/s12886-018-0731-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement